Brainstorm Cell Therapeutics reported 0 in Sales Revenues for its fiscal quarter ending in March of 2025.





Sales Change Date
Alterity Therapeutics Limited AUD 11.38K 10.23K Dec/2022
Biogen USD 2.28B 250M Dec/2025
Brainstorm Cell Therapeutics 0 0 Mar/2025
Cipla INR 75.18B 710M Dec/2025
Clal Biotechnology ILS 3.41M 2M Dec/2022
Compugen USD 1.89M 631K Sep/2025
CSL USD 3.54B 4.68B Jun/2025
Cytokinetics USD 1.93M 64.83M Sep/2025
Gilead Sciences USD 7.93B 130M Dec/2025
Grifols EUR 2.18B 37.55M Sep/2025
Halozyme Therapeutics USD 354M 148M Sep/2025
Mesoblast USD 13.2M 10.04M Jun/2025